According to Dir. 2001/83/EC, for biological medicinal products, “starting materials shall mean any
substance of biological origin such as micro-organisms, organs and tissues of either plant or animal
origin, cells or fluids (including blood or plasma) of human or animal origin, and biotechnological cell
constructs (cell substrates, whether they are recombinant or not, including primary cells).”